Canaan Inc. Provides August 2025 Bitcoin Production and Mining Operation Updates
Prnewswire· 2025-09-09 04:05
Bitcoins mined month-over-month increases 10%, bitcoin treasury hits 1,547 Total estimated computing power exceeds 10 EH/s globally SINGAPORE , Sept. 8, 2025 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today released its unaudited bitcoin mining update for the month ending August 31, 2025. ...
BGSF, Inc. Closes on Divestiture of Its Professional Division in $99 Million All-Cash Deal
Accessnewswire· 2025-09-09 04:05
PLANO, TX / ACCESS Newswire / September 8, 2025 / BGSF, Inc. (NYSE:BGSF), ("BGSF" or "the Company"), a leading provider of workforce solutions for the specialized property management industry, today announced the closing of its previously announced divestiture of its Professional Division to INSPYR Solutions, a portfolio company of A&M Capital Partners, for cash of $99 million. Interim Co-CEOs Kelly Brown and Keith Schroeder, in a joint statement, commented, "BGSF's next chapter is exciting as we invest, wi ...
PharmAla Completes Import of LaNeo MDMA for US Distribution
Globenewswire· 2025-09-09 04:05
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is happy to announce that it has completed import operations and release to the United States. PharmAla announced contracting of this new distribution site on March 24, 2025. “With the full onboarding of our distribution facility, PharmAla is ...
Mama's Creations Reports Second Quarter Fiscal 2026 Financial Results
Globenewswire· 2025-09-09 04:05
Continued Sales Momentum Drove 24% YoY Revenue Growth; Acquisition of Crown 1 Enterprises to Further Expand Customer Base, Operating Scale, and Revenue with $56 Million in Sales in 12 Months Ended June 30, 2025 EAST RUTHERFORD, NJ, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Mama’s Creations, Inc. (Nasdaq: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, today reported its financial results for the second quarter ended July 31, 2025. Financial Summary: Three Months Ended July 31, $ ...
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
Globenewswire· 2025-09-09 04:05
Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:35 p.m. ET on Wednesday, September 10th, 2025. A link to the live audio webcast, as well as a replay, will be available on the Company’s website under the Investors tab at Events and Presentations. ABOUT ENOVIS Enovis Corporation (NYSE: ENOV) is an innovation-driven medical te ...
CleanCore Solutions Acquires 285,420,000 DOGE with Strategic Goal to Accumulate First Milestone Target of 1 Billion DOGE in 30 Days as the Newly Launched Official Dogecoin Treasury
Globenewswire· 2025-09-09 04:05
OMAHA, Neb., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”) today announced that it has acquired 285,420,000 Dogecoin (“Dogecoin” or “DOGE”), representing approximately US$68 million, through its newly launched and Dogecoin Foundation-backed treasury strategy (the “Official Dogecoin Treasury” or “Treasury”). The Treasury has been established to strategically accumulate DOGE in anticipation of increased utility and adoption, driven by the eff ...
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
Globenewswire· 2025-09-09 04:05
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that it has received a strategic investment from Goose Capital and former Tanox, Inc. CEO Dr. Nancy T. Chang, Goose founding member. At Tanox, Dr. Chang and her team invented and developed FDA-approved XOLAIR® (omalizumab) for severe asthma, TROGARZO® (ibalizu ...
CompoSecure to Move Stock Exchange Listing to NYSE
Globenewswire· 2025-09-09 04:05
Ticker symbol to remain “CMPO”SOMERSET, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO) (“CompoSecure” or the “Company”) today announced that it will transfer the listing of its Class A common stock (Nasdaq: CMPO) to the New York Stock Exchange (“NYSE”) from the Nasdaq Global Market (“Nasdaq”). The Class A common stock will retain their existing stock ticker, CMPO. CompoSecure expects the Class A common stock to begin trading on the NYSE on September 23, 2025, when CompoSecure is e ...
Giga Metals to Launch September Geophysics Program at Turnagain Ni-Co project
Globenewswire· 2025-09-09 04:05
VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Scott Lendrum, CEO of Giga Metals Corp. (TSX.V: GIGA, OTCQB: GIGGF) announced today that following the closing of the non-brokered private placement on August 28, 2025, Giga Metals Corp. will undertake a geophysics program at its flagship Turnagain project in northern British Columbia. Giga has retained Simcoe Geoscience Limited to complete the work, and the initial phase of the program is expected to begin the week of September 15th. The progr ...
Rapport Announces Proposed Public Offering of Common Stock
Globenewswire· 2025-09-09 04:05
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that it has commenced an underwritten public offering of $250.0 million of shares of its common stock. All of the shares in the proposed offering are being offered by Rapport. In addition, R ...